Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202203029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Xueli Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Materials-Oriented Chemical Engineering, College of Chemical Engineering, Nanjing Tech University, Nanjing, 211816, China. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms, Biosensing Techniques. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 153 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Cancer is a malignant disease that endangers human life, especially owing to its high fatality rate; therefore, rapid and accurate early screening is needed to effectively improve the survival rate. Compared with traditional cancer detection methods, electrochemical biosensors that recognize cancer biomarkers in blood have the advantages of low invasiveness, fast diagnosis, and low cost. However, there is always a trade‐off between sensitivity and selectivity, which limits the detection of trace amounts of biomarkers produced in the early stages. To address this issue, an increasing number of nanomaterials with simultaneous improvements in both sensitivity and selectivity have recently been reported. In this review, different categories of state‐of‐the‐art electrochemical biosensors and their operating principles are introduced, and their respective advantages and disadvantages are described. Furthermore, the review discusses the existing detection strategies and performance of nanomaterial‐based cancer biosensors for biomarker recognition, providing overall guidance for the material selection of different biomarkers. Finally, the main challenges involving existing electrochemical cancer biosensors are evaluated to present the future development prospects of nanomaterials and detection strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Materials-Oriented Chemical Engineering, College of Chemical Engineering, Nanjing Tech University, Nanjing, 211816, China.
- Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, China.
ORCID-Profile: Zhenyu Chu
Förderung
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yuan, X., Lin, B., Liu, T., Zhang, W., Chu, Z., Gu, X., Ma, Z., & Jin, W. (2023). Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202203029
Vancouver
Yuan X, Lin B, Liu T, Zhang W, Chu Z, Gu X, et al. Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202203029
BibTeX
@article{Yuan2023,
author = {Yuan, Xueli and Lin, Bowen and Liu, Tao and Zhang, Wei and Chu, Zhenyu and Gu, Xiaoping and Ma, Zhengliang and Jin, Wanqin},
title = {Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202203029}
}
EUVIMED